62 Participants Needed

High-Intensity Exercise for Type 1 Diabetes

(FEEL-HIIT Trial)

RS
Overseen ByRoxane St-Amand
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Institut de Recherches Cliniques de Montreal
Must be taking: Insulin analogs
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine if adding high-intensity interval training to standard diabetes education helps people with type 1 diabetes better recognize low blood sugar. Participants will either follow the educational program alone or combine it with home-based exercise sessions (Home-based High Intensity Interval Training). Individuals who have had type 1 diabetes for at least five years and struggle to notice low blood sugar may be suitable candidates. The goal is to enhance their awareness and safety by reducing episodes of low blood sugar. As an unphased trial, this study provides a unique opportunity to contribute to innovative diabetes management strategies.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but you must be on a stable type of insulin for at least one month before joining. If you're not using an insulin analog, you may need to switch to one at least a month before starting the trial.

What prior data suggests that high-intensity interval training is safe for people with type 1 diabetes?

Research has shown that high-intensity interval training (HIIT) can be safely performed by people with type 1 diabetes. A review found that low-volume HIIT, such as the kind done at home, is generally manageable. One study examined a virtual home-based HIIT program for individuals with type 1 diabetes and demonstrated that participants could safely engage in this exercise without major issues.

Specifically, home-based HIIT may help reduce the fear of low blood sugar (hypoglycemia) and overcome other exercise barriers. This suggests that the training not only improves fitness but is also safe for those concerned about low blood sugar.

In summary, high-intensity interval training, when conducted at home and monitored online, appears to be a safe option for people with type 1 diabetes, with no significant problems reported in these studies.12345

Why are researchers excited about this trial?

Researchers are excited about the high-intensity exercise program for Type 1 Diabetes because it offers a unique, home-based approach to managing this condition. Unlike traditional methods that primarily focus on medication and dietary management, this program integrates High Intensity Interval Training (HIIT) to potentially improve blood sugar control. By incorporating short bursts of intense exercise with periods of rest, this method could enhance insulin sensitivity and glucose regulation, offering a new, active way to complement existing treatments. Plus, its home-based nature makes it more accessible and convenient, encouraging regular participation and long-term lifestyle changes.

What evidence suggests that this trial's treatments could be effective for type 1 diabetes?

Research shows that high-intensity interval training (HIIT) can help people with type 1 diabetes control blood sugar and improve heart health. In this trial, one group of participants will follow a home-based HIIT program combined with a standard educational program. Studies have found that doing HIIT at home can reduce the fear of low blood sugar and make exercise more accessible for people with diabetes. Other research has shown that HIIT can lower blood sugar after meals and decrease insulin levels. These benefits suggest that including HIIT in a diabetes management plan might help people better recognize and prevent low blood sugar episodes.13567

Who Is on the Research Team?

Dr. Rémi Rabasa-Lhoret — Royal ...

Rémi Rabasa-Lhoret

Principal Investigator

Institut de recherches cliniques de Montréal

Are You a Good Fit for This Trial?

This trial is for adults aged 18-65 with type 1 diabetes and a reduced ability to detect low blood sugar, who've had diabetes for at least five years. They must use or be willing to use a continuous glucose monitor and have stable insulin treatment. Exclusions include heart rate-affecting meds, pregnancy, physical limitations preventing exercise, severe diabetic complications, recent high-intensity training, uncontrolled hypertension or significant heart disease.

Inclusion Criteria

You need to have a device that can support the Polar Beat app and a heart rate monitor.
You have a condition that makes it hard for you to recognize when your blood sugar is too low.
I have been diagnosed with type 1 diabetes for 5 years or more.
See 3 more

Exclusion Criteria

My blood pressure is not higher than 160/100 mm Hg.
Your blood tests show abnormal results, or you have low levels of hemoglobin.
I have a lung condition that limits my ability to exercise.
See 13 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants are randomized to a 12-week program of standard educational program with or without high intensity interval training

12 weeks
Weekly virtual sessions with exercise specialist

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Home-based High Intensity Interval Training
Trial Overview The study tests if adding a home-based high intensity interval training (HIIT) program to standard educational sessions on hypoglycemia prevention can better restore awareness of low blood sugar in type 1 diabetics than education alone. Participants will either receive the education or combine it with HIIT over 12 weeks and track their progress using various tools like glucose monitors and questionnaires.
How Is the Trial Designed?
2Treatment groups
Active Control
Group I: Standard educational program combined with high intensity interval trainingActive Control13 Interventions
Group II: Standard educational programActive Control11 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Institut de Recherches Cliniques de Montreal

Lead Sponsor

Trials
72
Recruited
10,300+

Published Research Related to This Trial

A 6-week high-intensity interval training (HIIT) program significantly improved lower limb muscle power, ankle dorsiflexion range of motion, and dynamic balance in 19 individuals with type 1 diabetes mellitus, demonstrating its safety and efficacy.
Participants in the HIIT group showed notable improvements in squat execution velocity (up to 11.3%) and dynamic balance across various directions, while the control group showed no significant changes, highlighting HIIT's effectiveness in enhancing physical functionality for those with T1DM.
Effect of a HIIT protocol on the lower limb muscle power, ankle dorsiflexion and dynamic balance in a sedentary type 1 diabetes mellitus population: a pilot study.Alarcón-Gómez, J., Martin Rivera, F., Madera, J., et al.[2022]
Exercise training, particularly a combination of strength exercises and high-intensity interval training, may help reduce the risk of hypoglycemia in individuals with Type 1 diabetes mellitus (T1DM) compared to continuous aerobic exercise.
This proposed training regimen, performed three times a week, aims to improve long-term health markers and reduce the risk of complications associated with T1DM by enhancing glycemic control and overall physical fitness.
Exercise for type 1 diabetes mellitus management: General considerations and new directions.Farinha, JB., Krause, M., Rodrigues-Krause, J., et al.[2022]
High Intensity Interval Training and Resistance training (HIITR) significantly improved heart rate variability (HRV), aerobic capacity (VO2peak), and levels of beneficial plasma biomarkers like HDL-C in adolescents with type 1 diabetes after 12 weeks of training.
The study found that exercise training led to significant reductions in HbA1c and fasting blood sugar levels, highlighting the potential of HIITR to enhance cardiovascular health and metabolic control in this population.
A High intensity Interval training (running and swimming) and resistance training intervention on heart rate variability and the selected biochemical factors in boys with type 1 diabetes.Saki, H., Nazem, F., Fariba, F., et al.[2023]

Citations

1.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/31584734/
Home-based high-intensity interval training reduces ...Home-HIT seems to offer a strategy to reduce fear of hypoglycaemia, while simultaneously removing other known barriers that prevent people with type 1 diabetes ...
Effectiveness and Safety of High-Intensity Interval Training ...Recent research has shown that high-intensity interval training (HIIT) can promote improvements in glucose control and cardiovascular health in individuals ...
Home‐based high‐intensity interval training reduces ...The conclusion of this review is that Home-HIT seems to offer a strategy to reduce fear of hypoglycaemia, while simultaneously removing other known barriers ...
The impact of high-intensity interval training on ...Our results demonstrated that both HIIT and MICT are effective for reducing postprandial glycemia and insulinemia, particularly by moderate-duration ...
The Effect of High-Intensity Interval Training on Blood Glucose ...This study aims to investigate the effect of High-Intensity Interval Training on blood glucose levels in patients with type 2 diabetes mellitus ...
A Multidisciplinary Evaluation of a Virtually Supervised Home ...This study used a multidisciplinary approach to evaluate a novel, virtually monitored home-based HIT (Home-HIT) intervention in people with type 1 diabetes.
NCT04825366 | Restoration of Hypoglycemia Awareness ...The objective of this study is to investigate if the addition of a 12-week program of home-based high intensity interval training to a standard educational ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security